Clinical trials
Phase 2 Bronchiolitis Obliterans Syndrome trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
144 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2003 | 3 |
| 2004 | 3 |
| 2005 | 2 |
| 2006 | 6 |
| 2007 | 6 |
| 2008 | 9 |
| 2009 | 5 |
| 2010 | 6 |
| 2011 | 9 |
| 2012 | 4 |
| 2013 | 5 |
| 2014 | 3 |
| 2015 | 11 |
| 2016 | 10 |
| 2017 | 4 |
| 2018 | 3 |
| 2019 | 5 |
| 2020 | 8 |
| 2021 | 8 |
| 2022 | 4 |
| 2023 | 5 |
| 2024 | 9 |
| 2025 | 9 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 70 |
| Terminated | 25 |
| Recruiting | 22 |
| Unknown status | 18 |
| Withdrawn | 4 |
| Active, not recruiting | 3 |
| Suspended | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 7 |
| AstraZeneca | 6 |
| Dana-Farber Cancer Institute | 6 |
| Fred Hutchinson Cancer Center | 6 |
| National Cancer Institute (NCI) | 4 |
| Gilead Sciences | 3 |
| Incyte Corporation | 3 |
| Kadmon, a Sanofi Company | 3 |
| Northside Hospital, Inc. | 3 |
| Dey | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bronchiolitis Obliterans Syndrome | 144 |
| Graft vs Host Disease | 15 |
| Leukemia | 14 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 9 |
| Pulmonary Disease, Chronic Obstructive | 8 |
| Pain | 7 |
| Bronchiolitis Obliterans | 6 |
| Lymphoma, Follicular | 6 |
| Hepatitis C | 5 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 5 |
Trials
Showing 76 to 100 of 144. Each trial links to its page on Pharma Observatory.
44 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.